Get All Access for $5/mo

Novavax Covid-19 Vaccine Over 90% Effective, Study Shows The biotech firm says the vaccine uses a third type of technology.

By Euni Han Edited by Emily Rella

Opinions expressed by Entrepreneur contributors are their own.

SOPA Images | Getty Images

Novavax's COVID-19 vaccine showed an overall efficacy of 90.4% in trials and offered 100% protection in some cases, says CEO Stanley Erck in a company release.

"These clinical results reinforce that NVX-CoV2373 is extremely effective and offers complete protection against both moderate and severe COVID-19 infection," he wrote.

The vaccine also demonstrated 93% efficacy against circulating variants, says Dr. Gregory M. Glenn, Novovax's President of Research and Development.

Related: Grocery Chain to Give Away $5 million to Vaccinated Customers

"These data show consistent, high levels of efficacy and reaffirm the ability of the vaccine to prevent COVID-19 amid ongoing genetic evolution of the virus. Our vaccine will be a critical part of the solution to COVID-19 and we are grateful to the study participants and trial staff who made this study possible."

The trial included 29,960 volunteers in the U.S. and Mexico: 20% were Latin American, 12% were African American, 7% were Native American, 5% were Asian and 13% were over 65 years old. None of the participants receiving the drug fell seriously ill.

Related: These 7 Countries are Now Accepting Vaccine Passports

Common side effects included pain around the injection site, muscle aches and fatigue.

Novavax says its vaccine uses a third type of technology that delivers the protein antigen directly inside the body within tiny particles. A booster then strengthens the body's immune response.

The Gaithersburg, Maryland firm, which received $1.6 billion in federal funding, also says its drug development took longer due to its smaller size, USA TODAY reports.

But once final chemistry, manufacturing and controls requirements are met, Novavax plans to file for regulatory authorization during the summer --- saying its on track to manufacture 100 million doses a month by the end of the third quarter, and 150 million doses a month by the final quarter of 2021.

Related: This robot will tell you when and how to get vaccinated

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Editor's Pick

Business News

Wells Fargo Reportedly Fired More Than a Dozen Employees for Faking Keyboard Activity

The bank told Bloomberg that it "does not tolerate unethical behavior."


The Key to Real Innovation Is Cross-Pollination — Here Are 10 Ways to Implement It in Your Business

Transform your business with this unique approach to sparking innovation.

Business Models

5 Questions to Ask to Make Sure Your Company's Financial Plan Is on Track

Conducting a "check-up" at midyear is essential to maintain a healthy financial plan.


7 Ways You Might Be Damaging Your Credibility as an Entrepreneur

Here are seven credibility killers entrepreneurs need to be aware of.

Business Solutions

Why Every Solopreneur Needs to Embrace AI-Powered Teams

With the right approach, solopreneurs can harness AI to drive efficiency, productivity and business growth.

Side Hustle

These Are the 10 Best Online Side Hustles of 2024 to Earn Extra Cash

From teaching to testing artificial intelligence, these side hustles can earn you quick cash from home.